105 related articles for article (PubMed ID: 27288151)
1. Monocyte aggregates: A clue to an unsuspected monoclonal B-cell lymphoproliferative disorder.
Nguyen L; Cleveland R; Kass L
Am J Hematol; 2016 Sep; 91(9):E360-1. PubMed ID: 27288151
[No Abstract] [Full Text] [Related]
2. Auer rod-like inclusions in monoclonal B-cell lymphoproliferative disorder: A potential diagnostic pitfall.
Sojitra P; Nam MW; Omman R; Velankar MM
Pathol Int; 2017 Feb; 67(2):113-115. PubMed ID: 27976825
[No Abstract] [Full Text] [Related]
3. Identification of IG-clonality status as a pre-treatment predictor for mortality in patients with immunodeficiency-associated Epstein-Barr virus-related lymphoproliferative disorders.
van der Velden WJ; Nissen L; van Rijn M; Rijntjes J; de Haan A; Venkatraman L; Catherwood M; Liu H; El-Daly H; van de Laar L; Craenmehr MH; van Krieken JH; Stevens WB; Groenen PJ
Haematologica; 2015 Apr; 100(4):e152-4. PubMed ID: 25527569
[No Abstract] [Full Text] [Related]
4. Intraclonal heterogeneity in concomitant monoclonal lymphocyte and plasma cell populations: combining flow cytometric cell sorting with molecular monoclonality profiling.
Zehentner BK; de Baca ME; Wells DA; Loken MR
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):214-7. PubMed ID: 23490988
[TBL] [Abstract][Full Text] [Related]
5. Clinical and phenotypic features of CD5-negative B cell chronic lymphoproliferative disease resembling chronic lymphocytic leukemia.
Romano C; Sellitto A; Chiurazzi F; Simeone L; De Fanis U; Raia M; Del Vecchio L; Lucivero G
Int J Hematol; 2015 Jan; 101(1):67-74. PubMed ID: 25432435
[TBL] [Abstract][Full Text] [Related]
6. Translocation (18;22)(q21;q11.2) in B-cell lymphoproliferative disorders: a report of six cases.
Britos-Franco P; Rodríguez-Hernández I; Navarro JT; Granada I; Tapia G; Juncà J; Ribera JM; Millá F
Leuk Lymphoma; 2015 Mar; 56(3):789-92. PubMed ID: 24884313
[No Abstract] [Full Text] [Related]
7. Occult B-cell lymphoproliferative disorders.
Rawstron AC
Histopathology; 2011 Jan; 58(1):81-9. PubMed ID: 21261685
[TBL] [Abstract][Full Text] [Related]
8. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric immunophenotyping in posttransplant lymphoproliferative disorders.
Dunphy CH; Gardner LJ; Grosso LE; Evans HL
Am J Clin Pathol; 2002 Jan; 117(1):24-8. PubMed ID: 11789726
[TBL] [Abstract][Full Text] [Related]
10. Molecular and flow cytometry characterization during the follow-up of three simultaneous lymphoproliferative disorders: hairy cell leukemia, monoclonal B-cell lymphocytosis, and CD4(++) /CD8(+/- dim) T-large granular lymphocytosis--a case report.
Garrido P; Jiménez P; Sánchez C; Valero F; Balanzategui A; Almagro M; López P; de Pablos JM; Navarro P; Cabrera A; González M; Jurado M; Ruiz-Cabello F
Cytometry B Clin Cytom; 2011 May; 80(3):195-200. PubMed ID: 21520406
[TBL] [Abstract][Full Text] [Related]
11. CD200 expression in B-cell chronic lymphoproliferative disorders.
El Desoukey NA; Afify RA; Amin DG; Mohammed RF
J Investig Med; 2012 Jan; 60(1):56-61. PubMed ID: 22064604
[TBL] [Abstract][Full Text] [Related]
12. Development of monomorphic B-cell plasmacytoma post-transplant lymphoproliferative disorder in a patient with previous autologous stem cell transplant.
Oon ML; Soon G; Poon LM; Wang S
Pathology; 2019 Oct; 51(6):644-646. PubMed ID: 31470993
[No Abstract] [Full Text] [Related]
13. An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder.
Patel JL; Shetty S; Salama ME
Am J Dermatopathol; 2011 May; 33(3):e31-6. PubMed ID: 20861710
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic value of CD1d expression in a large cohort of patients with B-cell chronic lymphoproliferative disorders.
Kotsianidis I; Nakou E; Spanoudakis E; Bouchliou I; Moustakidis E; Miltiades P; Vadikolia CM; Szydlo R; Karadimitris A; Tsatalas C
Am J Clin Pathol; 2011 Sep; 136(3):400-8. PubMed ID: 21846915
[TBL] [Abstract][Full Text] [Related]
15. Clonal T-large granular lymphocyte proliferations associated with clonal B cell lymphoproliferative disorders: report of eight cases.
Papadaki T; Stamatopoulos K; Kosmas C; Paterakis G; Kapsimali V; Kokkini G; Economopoulos T; Stefanoudaki-Sofianatou K; Marinakis T; Gardikas E; Kalmantis T
Leukemia; 2002 Oct; 16(10):2167-9. PubMed ID: 12357377
[No Abstract] [Full Text] [Related]
16. [Immunophenotyping of B chronic lymphoproliferative syndromes (CLL excluded): confrontation with the histology].
El Borgi W; Ben Salah N; Ben Lakhal F; Makni L; Gouider E; Hafsia R
Ann Biol Clin (Paris); 2013; 71(6):693-7. PubMed ID: 24342790
[TBL] [Abstract][Full Text] [Related]
17. Discrimination of biclonal B-cell chronic lymphoproliferative neoplasias by tetraspanin antigen expression.
Barrena S; Almeida J; Yunta M; López A; Díaz-Mediavilla J; Orfao A; Lazo PA
Leukemia; 2005 Sep; 19(9):1708-9. PubMed ID: 15973446
[No Abstract] [Full Text] [Related]
18. Monoclonal lymphocytosis with villous lymphocytes: a chronic lymphoproliferative disease of CD11c+ B-cells.
Bassan R; Neonato MG; Abbate M; Motta T; Barbui T; Rambaldi A
Leukemia; 1991 Sep; 5(9):799-806. PubMed ID: 1682536
[TBL] [Abstract][Full Text] [Related]
19. The utility of the BIOMED-2 primers in the detection of 2 clonal, B-lymphoproliferative disorders simultaneously involving the same site.
Ly B; Cotta CV
Arch Pathol Lab Med; 2013 Nov; 137(11):1654-9. PubMed ID: 24168505
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the Bruton Tyrosine Kinase Pathway in B-Cell Lymphoproliferative Disorders.
Castillo JJ; Treon SP; Davids MS
Cancer J; 2016; 22(1):34-9. PubMed ID: 26841015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
